ReadYourDNA

FOLFOX Chemo Regimen

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About FOLFOX Chemo Regimen

What it is

FOLFOX is a chemotherapy combination of folinic acid (leucovorin), fluorouracil (5-FU) and oxaliplatin, given by drip every two weeks. It is a standard treatment for bowel cancer, both after surgery and for advanced disease, often with an antibody such as bevacizumab or panitumumab, and is also used for stomach and oesophageal cancers.

How genes come into it

For the medicines in FOLFOX, the strongest gene evidence concerns fluorouracil: people with low-function DPYD variants clear it poorly, with a much higher chance of severe side effects, and CPIC and DPWG have published guidelines on DPYD and fluorouracil (see its own page). The studies listed for the regimen itself looked at DPYD and TYMS, fluorouracil's target, for response and side effects.

What research found

Every published finding on gene variants and FOLFOX Chemo Regimen. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

TYMS rs45445694: Level 3. Efficacy: overall survival, Progression-free survival. 13.

TYMS rs11280056: Level 3. Toxicity: Neoplasms. 5.

Response (3 findings)

Studies of how well it worked in people carrying a variant.

DPYD rs1801159: Genotypes CC + CT is not associated with response to FOLFIRI, FOLFOX, irinotecan or oxaliplatin in people with Colorectal Neoplasms as compared to genotype TT.

DPYD rs1801265: Genotypes AG + GG is not associated with response to FOLFIRI, FOLFOX, irinotecan or oxaliplatin in people with Colorectal Neoplasms as compared to genotype AA.

DPYD rs3918290: Genotype CT is not associated with response to FOLFIRI, FOLFOX, irinotecan or oxaliplatin in people with Colorectal Neoplasms as compared to genotype CC.

Side effects (1 finding)

Studies of side effects in people carrying a variant.

DPYD DPYD c.1129-5923C>G, c.1236G>A (HapB3), DPYD c.2846A>T: DPYD c.2846A>T + c.1129-5923C>G, c.1236G>A (HapB3) is not associated with decreased clinical benefit to fluorouracil, FOLFIRINOX, FOLFOX or XELOX in people with Colorectal Neoplasms, Stomach Neoplasms, Gallbladder Neoplasms or Pancreatic Neoplasms.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

5-FU (Antimetabolites)

ABT-751 (Antimitotics)

Adriamycin (Anthracyclines)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com